Data on efficacy outcomes of endovascular versus surgical revascularization in patients with critical limb ischemia (CLI) in contemporary practice are limited. In this prospective cohort study, 353 consecutive patients with CLI were enrolled and allocated to endovascular (PTA [percutaneous transluminal angioplasty]), surgical (SURG), or no revascularization (No REVASC) after interdisciplinary consensus. Outcome measures were sustained primary clinical success (sPCS; survival without major amputation, repeated target extremity revascularization, and freedom from CLI), limb salvage, and amputation-free survival. Propensity-matched Kaplan-Meier analyses and stratified log-rank tests were performed. The PTA, SURG, and No REVASC groups consisted of 264, 62, and 27 patients, respectively. Compared to SURG patients, PTA patients were significantly older, had more risk factors, and more often had ischemic lesions. Propensity score-adjusted analyses showed no significant differences: sPCS was 51.3%/52.2%, limb salvage rate 91.5%/93.7%, and major amputation-free survival 90.5%/87.2% at 12 months for PTA and SURG, respectively. Amputation-free survival for the No REVASC group was 69% at 12 months. In conclusion, endovascular and surgical revascularization in CLI has comparable efficacy outcomes after 12 months. Contemporary overall outcome of patients with CLI is considerably better compared to earlier studies.
SigvantBKragstermanBFalkenbergM. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg. 2016;64(4):1009–17.e3.
7.
BalmerHMahlerFDoDDTrillerJBaumgartnerI. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther. 2002;9(4):403–10.
8.
DanielssonGAlbrechtssonUNorgrenL. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg. 2001;21(5):432–6.
9.
BowersBLValentineRJMyersSIChervuAClagettGP. The natural history of patients with claudication with toe pressures of 40 mm Hg or less. J Vasc Surg. 1993;18(3):506–11.
10.
BrosiPDickFDoDDSchmidliJBaumgartnerIDiehmN. Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg. 2007;46(6):1198–207.
11.
DickFDiehmNGalimanisAHusmannMSchmidliJBaumgartnerI. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg. 2007;45(4):751–61.
12.
SlovutDPSullivanTM. Critical limb ischemia: medical and surgical management. Vasc Med. 2008;13(3):281–91.
13.
MalyarNMFreisingerEMeyborgM. Low rates of revascularization and high in-hospital mortality in patients with ischemic lower limb amputation: morbidity and mortality of ischemic amputation. Angiology. 2016;67(9):860–9.
JaccardYWaltherSAndersonS. Influence of secondary infection on amputation in chronic critical limb ischemia. Eur J Vasc Endovasc Surg. 2007;33(5):605–9.
16.
BaumgartnerISchainfeldRGrazianiL. Management of peripheral vascular disease. Annu Rev Med. 2005;56:249–72.
17.
AbdelhamidMFDaviesRSRaiSHopkinsJDDuddyMJVohraRK. Below-the-ankle angioplasty is a feasible and effective intervention for critical leg ischaemia. Eur J Vasc Endovasc Surg. 2010;39(6):762–8.
AdamDJBeardJDClevelandT. Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.
21.
FernandezNMcEnaneyRMaroneLK. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg. 2011;54(3):722–9.
22.
DosluogluHHLallPHarrisLMDryjskiML. Long-term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular-first approach by vascular surgeons. J Vasc Surg. 2012;56(2):361–71.
23.
GoodneyPPBeckAWNagleJWelchHGZwolakRM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50(1):54–60.
24.
RollinsKECoughlinPA. Functional outcomes following revascularisation for critical limb ischaemia. Eur J Vasc Endovasc Surg. 2012;43(4):420–5.
OrtmannJNueschECajoriG. Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis. J Vasc Surg. 2011;54(6):1668–78.
27.
OrtmannJGahlBDiehmNDickFTraupeTBaumgartnerI. Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency. J Vasc Surg. 2012;56(3):737–45.
28.
WillenbergTBaumannFEisenbergerUBaumgartnerIDoDDDiehmN. Impact of renal insufficiency on clinical outcomes in patients with critical limb ischemia undergoing endovascular revascularization. J Vasc Surg. 2011;53(6):1589–97.
29.
DiehmNSavolainenHMahlerFSchmidliJDoDDBaumgartnerI. Does deep femoral artery revascularization as an isolated procedure play a role in chronic critical limb ischemia?J Endovasc Ther. 2004;11(2):119–24.
30.
KrogerKStangAKondratievaJ. Prevalence of peripheral arterial disease—results of the Heinz Nixdorf recall study. Eur J Epidemiol. 2006;21(4):279–85.
31.
DormandyJARutherfordRB. Management of peripheral arterial disease (PAD). TASC working group. Transatlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 pt 2):S1–S296.
32.
Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg. 1992;6(suppl A):1–32.
EmanueleMABuchananBJAbrairaC. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care. 1981;4(2):289–92.
35.
HirschATHaskalZJHertzerNR. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol. 2006;47(6):1239–312.
36.
DiehmCDiehmN. Non-invasive treatment of critical limb ischemia. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4(3):241–7.
37.
RutherfordRBBakerJDErnstC. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–38.
38.
DiehmNBaumgartnerIJaffM. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J. 2007;28(7):798–805.
39.
DiehmNSilvestroADoDD. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J Endovasc Ther. 2005;12(6):723–30.
40.
LuntM. Selecting an appropriate caliper can be essential for achieving good balance with propensity score matching. Am J Epidemiol. 2014;179(2):226–35.
LeysCLeyCKleinOBernardPLicataL. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49(4):764–6.
43.
TaylorSMCullDLKalbaughCA. Critical analysis of clinical success after surgical bypass for lower-extremity ischemic tissue loss using a standardized definition combining multiple parameters: a new paradigm of outcomes assessment. J Am Coll Surg. 2007;204(5):831–8; discussion 838-9.
O’Brien-IrrMSDosluogluHHHarrisLMDryjskiML. Outcomes after endovascular intervention for chronic critical limb ischemia. J Vasc Surg. 2011;53(6):1575–81.
46.
VrauxHHammerFVerhelstRGoffettePVandeleeneB. Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg. 2000;20(2):441–6.
47.
DosluogluHHLallPCherrGSHarrisLMDryjskiML. Superior limb salvage with endovascular therapy in octogenarians with critical limb ischemia. J Vasc Surg. 2009;50(2):305–15, 316.e1–2; discussion 315-6.
48.
TaylorSMYorkJWCullDLKalbaughCACassALLanganEM3rd. Clinical success using patient-oriented outcome measures after lower extremity bypass and endovascular intervention for ischemic tissue loss. J Vasc Surg. 2009;50(3):534–41; discussion 541.
49.
PatelSDBiasiLParaskevopoulosI. Comparison of angioplasty and bypass surgery for critical limb ischaemia in patients with infrapopliteal peripheral artery disease. Br J Surg. 2016;103(13):1815–22.
50.
ArvelaEVenermoMSoderstromM. Infrainguinal percutaneous transluminal angioplasty or bypass surgery in patients aged 80 years and older with critical leg ischaemia. Br J Surg. 2011;98(4):518–26.
51.
HicksCWNajafianAFarberA. Below-knee endovascular interventions have better outcomes compared to open bypass for patients with critical limb ischemia. Vasc Med. 2017;22(1):28–34.
52.
SoderstromMIArvelaEMKorhonenM. Infrapopliteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia: a propensity score analysis. Ann Surg. 2010;252(5):765–73.
53.
BradburyAWAdamDJBellJ. Bypass versus angioplasty in severe ischaemia of the leg (basil) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(suppl 5):5S–17S.
54.
KumbhaniDJStegPGCannonCP. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35(41):2864–72.
55.
RehringTFSandhoffBGStolcpartRSMerenichJAHollisHWJr. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg. 2005;41(5):816–22.
56.
PandeRLPerlsteinTSBeckmanJACreagerMA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124(1):17–23.
